Parathyroid Disease

What Is Parathyroid Disease?

Parathyroid disease refers to disorders of the four small parathyroid glands located in the neck, just behind the thyroid gland. These glands produce parathyroid hormone (PTH), which helps regulate the body’s calcium and phosphorus balance. When parathyroid glands produce too much or too little hormone, calcium levels in the blood may become unhealthy, leading to symptoms that can affect bones, kidneys, muscles, and the digestive and nervous systems.:contentReference[oaicite:0]{index=0}

Types of Parathyroid Disorders

The most common parathyroid condition is hyperparathyroidism, in which one or more of the glands produces too much PTH. This often leads to high blood calcium (hypercalcemia). Primary hyperparathyroidism is usually caused by an enlarged gland or benign tumor (adenoma), while secondary hyperparathyroidism arises from another condition such as kidney disease or long‑standing vitamin D deficiency. Tertiary hyperparathyroidism can develop when the glands remain overactive even after the original cause has been treated. Rarely, parathyroid cancer may be the cause.

Signs and Symptoms

Parathyroid disease may be discovered during routine blood testing before symptoms appear. When symptoms do occur, they are often related to elevated or low calcium levels and may include:

  • Fatigue, weakness, or low energy
  • Bone or joint pain and fragile bones
  • Kidney stones or frequent urinary problems
  • Abdominal discomfort, nausea, or constipation
  • Mood changes, depression, or difficulty concentrating
  • Increased thirst and frequent urination

Because these symptoms can overlap with many other conditions, blood tests for calcium and PTH are essential for diagnosis.

Diagnosis and Evaluation

Diagnosis typically begins with blood tests showing elevated calcium and parathyroid hormone levels. Additional tests may include:

  • Blood tests to measure calcium, phosphorus, and PTH
  • Imaging studies, such as ultrasound, sestamibi scan, CT, or MRI, to locate abnormal glands before surgery
  • Bone density scans if bone loss is a concern

A comprehensive evaluation helps differentiate types of parathyroid disease and guides treatment planning.

Treatment Options

Treatment depends on the underlying cause and severity of the disease. Many patients with primary hyperparathyroidism benefit from surgical removal of the overactive gland(s), called parathyroidectomy, which is often curative and improves calcium balance. Minimally invasive parathyroidectomy may be possible when imaging localizes a single overactive gland. In other cases, more extensive exploration may be needed. Non‑surgical options and medications may be recommended for patients who are not surgical candidates or for secondary hyperparathyroidism related to chronic conditions.

Divisions Involved in Your Care

Procedures We Use

Frequently Asked Questions

Parathyroid disease most often results from one or more glands producing too much parathyroid hormone. This is usually due to an enlarged gland or benign tumor (adenoma). Secondary causes include kidney disease or long‑term vitamin D deficiency triggering increased hormone production.

Symptoms typically stem from abnormal calcium levels and may include fatigue, bone or joint pain, kidney stones, abdominal discomfort, mood changes, and frequent urination.

Diagnosis is made through blood tests measuring calcium and PTH levels. Imaging studies like ultrasound or sestamibi scans help locate diseased glands before surgery.

Surgery (parathyroidectomy) is the most common and often curative treatment for primary hyperparathyroidism. Non‑surgical options or medications may be considered for secondary hyperparathyroidism or in patients who cannot undergo surgery.

Most patients experience improved calcium balance and relief of symptoms. Recovery is typically quick, especially with minimally invasive techniques, but follow‑up is important to monitor calcium levels.

Recurrence is possible, especially if not all abnormal glands are identified and treated. Long‑term follow‑up and monitoring help detect any return early.